ETON
Eton Pharmaceuticals, Inc.
Key Financials
Gross Profit
$42.7M
↑ 82.6%
Revenue
$80.0M
↑ 104.9%
Net Income
$-4601000
↓ 20.4%
Total Assets
$92.1M
↑ 21.0%
Operating Income
$-844000
↑ 67.5%
EPS (Diluted)
$0.41
N/A
Cash & Equivalents
$25.9M
↑ 73.7%
Shareholders' Equity
$26.2M
↑ 7.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/6/2026 | View on SEC |
| 144 | 10/6/2026 | View on SEC |
| 8-K | 9/28/2026 | View on SEC |
| 4/A | 8/31/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
| 144 | 8/28/2026 | View on SEC |
| 4 | 8/24/2026 | View on SEC |
| 144 | 8/24/2026 | View on SEC |
| 4 | 8/20/2026 | View on SEC |
| 144/A | 8/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ETON |
| Company Name | Eton Pharmaceuticals, Inc. |
| CIK | 1710340 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (847) 787-7361 |